NEWS, REPORTS & POSITION STATEMENTS 1. Emulate Liver-Chip accepted into the FDA ISTAND Pilot Program The Emulate Liver-Chip has been accepted into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program — the first Organ-on-a-Chip technology to achieve this […]
NEWS, REPORTS & POSITION STATEMENTS 1. Chemicals regulation and non-animal methods : displacing the gold standard Animal methods are increasingly seen as no longer the ‘gold standard’ for several reasons. In a new paper, Annamaria Carusi, Consulting Specialist at InterChange Research, […]
NEWS, REPORTS & POSITION STATEMENTS 1. The FDA Modernization Act 3.0 : Paving the Way for a New Era in Drug Development — or Just a Gentle Nudge ? Opinion piece from the CEO of InSphero biotech, Jan Lichtenberg In a significant step toward […]
NEWS, REPORTS & POSITION STATEMENTS 1. Accelerating the transition : Key recommendations the EU must adopt The EU’s approach to phasing out animal testing needs rapid acceleration, and by doing so the EU can set a new industry standard in chemical safety […]
NEWS, REPORTS & POSITION STATEMENTS 1. Report of the European Commission workshop on “The Roadmap Towards Phasing Out Animal Testing for Chemical Safety Assessments” This report summarises the main findings and discussion from the European Commission (EC) workshop on “The […]